In contrast, plasma levels of lipoteichoic acid (LTA), being a ligand of TLR2 and 6 as well as TLR115, were not different between controls and NAFLD patients (Fig. 3D). The gene discussed is TLR2; the disease is metabolic dysfunction-associated steatotic liver disease.